Citation tools
"Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial)." Clinical Cancer Research
14.13
(2008):
4192-4199.
Web. 23 Jan. 2021.